Versartis publishes 2 preclinical abstracts at American Diabetes Association meeting Jun 6, 2009
New company focusing on extending half life of drugs for metabolic and endocrine diseases. New Orleans, LA June 5, 2009 Versartis, Inc., a new company developing novel biologics with enhanced properties for patients with metabolic diseases, published abstracts for preclinical data on its two product candidates, VRS-859 (exenatide-rPEG) and VRS-808 (glucagon-rPEG), at the American Diabetes Association Scientific Sessions annual meeting beginning today in New Orleans. (EurekAlert! -- Business News)
Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference Mar 25, 2009
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. (PR Newswire)
Like Owner, Like Dog: One Third Of US Dogs Are Obese, Cats Also Suffer Feb 22, 2008
There are also endocrine diseases that are associated with obesity that must also be considered and ruled out, before the pet undergoes weight reduction, said Thatcher. Like humans, there are also many health problems associated with being obese. (Science Daily)
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma Dec 4, 2007
The Company creates innovative medicines and products for women s and reproductive health, endocrine diseases and cell-based therapies. With a proven track record of developing and commercializing products in its key therapeutic areas, the Company also has an internal pipeline of new products in development in women s and reproductive health and hormonal cancer therapy. (BusinessWire)
Kids mature faster due to diet, porn Sep 5, 2007
The number of children experiencing the early onset of puberty has doubled over the past 10 years, according to a survey analyzing children's endocrine diseases by the Women and Children's Hospital of Guangdong Province. The survey found the average age for the onset of puberty of Guangzhou's children dropped to 11 years old from the previous age of 13. (Xinhuanet, China)
Pfizer Inc UK Regulatory Announcement: Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009 Aug 7, 2007
The pipeline includes 20 potential treatments for cancer; 16 for cardiovascular, metabolic and endocrine diseases; 17 for pain and inflammation; 17 for neurological disorders and 10 for infectious diseases ... Pfizer continues to build on its traditional strengths in cardiovascular research and has expanded in metabolic and endocrine diseases. (BusinessWire)
Two govt hospitals to adopt 'Full Paying Patient' concept Jul 27, 2007
Dr Chua said the ministry picked the two hospitals as they were excellent medical centres in treating liver related illness, hand surgery, breast cancer, endocrine diseases and some other illness. He said many who could afford sought treatment at these hospitals, but without the full paying patient concept, they only paid the minimal rate and enjoyed the subsidised treatment. (The Star Online, Malaysia -- News)
Rise in abortions marks a changing society in China May 13, 2007
However, Xu noted that young women who have multiple abortions are more susceptible to problems like infertility, hemorrhaging, endocrine diseases and endometriosis. A recent survey of 8,846 single and married women at 10 hospitals in Beijing found that 36 percent had had more than one abortion within six months. (International Herald Tribune)
